UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000041353
Receipt No. R000047212
Scientific Title Comparison of remimazolam and propofol on emergence in awake craniotomy: a randomized comparative study
Date of disclosure of the study information 2020/08/11
Last modified on 2020/08/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Comparison of remimazolam and propofol on emergence time in patients who undergo awake craniotomy: a randomized comparative study
Acronym Efficacy of remimazolam and propofol in awake craniotomy
Scientific Title Comparison of remimazolam and propofol on emergence in awake craniotomy: a randomized comparative study
Scientific Title:Acronym Efficacy of remimazolam and propofol in awake craniotomy
Region
Japan

Condition
Condition brain tumor
Classification by specialty
Anesthesiology Neurosurgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Awake craniotomy is applied for resection of brain tumor in temporal lobe and performed to improve the postoperative function. The aim of this study is the comparison of remimazolam, ultra-short acting benzodiazepin, and propofol, conventional sedative, concerning about time needed for emergence from anesthesia.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Time needed for emergence from general anesthesia
Key secondary outcomes Time needed for extubation
Time course of sedation score
Time course of bispectral index
Serum concentration of remimazolam
Blood pressure, heart rate and SpO2 during general anesthesia
Incidence of awake craniotomy failure
Incidence of flumazenil administration
Doses of sedatives at re-anesthetic induction
Time needed for re-anesthetic induction

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Remimazolam is administered as a sedative in awake craniotomy
Interventions/Control_2 Propofol is administered as a sedative in awake craniotomy
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
65 years-old >
Gender Male and Female
Key inclusion criteria Patients who undergo awake craniotomy using asleep-awake-asleep procedure
Patients whose ASA-PS is 1 or 2, indicating their physical status are good
Key exclusion criteria Patients diagnosed as severe cognitive dysfunction in preoperative period
Patients who have allergy for propofol, remimazolam and flumazenil
Patients who have severe hepatic dysfunction and/or renal dysfunction
Patients determined as inappropriate to include by researcher of this study
Target sample size 126

Research contact person
Name of lead principal investigator
1st name Shunsuke
Middle name
Last name Tachibana
Organization Sapporo Medical University School of Medicine
Division name Department of Anesthesiology
Zip code 0608543
Address 291, South 1, West 16, Chuo-ku, Sapporo
TEL 011-611-2111
Email shunsuke.tachibana@gmail.com

Public contact
Name of contact person
1st name Tomohiro
Middle name
Last name Chaki
Organization Sapporo Medical University School of Medicine
Division name Department of Anesthesiology
Zip code 0608543
Address 291, South 1, West 16, Chuo-ku, Sapporo
TEL 011-611-2111
Homepage URL
Email chakitomohiro0728@yahoo.co.jp

Sponsor
Institute Sapporo Medical University School of Medicine
Institute
Department

Funding Source
Organization Sapporo Medical University School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization IRB of Sapporo Medical School of University Hospital
Address 291, South 1, West 16, Chuo-ku, Sapporo
Tel 011-611-2111
Email chakitomohiro0728@yahoo.co.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 08 Month 11 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 08 Month 03 Day
Date of IRB
Anticipated trial start date
2020 Year 08 Month 11 Day
Last follow-up date
2025 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 08 Month 07 Day
Last modified on
2020 Year 08 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047212

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.